The management of patients with some conditions can be complicated, and as a result it may not be possible to fully discharge patients from hospital back to the care of their General Practitioner (GP). Therefore, a system of Shared Care encompassing primary and hospital out-patient care is appropriate. You can access the list below for those medicines that have an agreed Shared Care Protocol within Cardiff and Vale UHB.
Shared care supporting documents:
Shared care list – Please print only when needed in order to ensure that the most up to date shared care protocol is accessed.
(Access the list of Shared Care Protocols below )
The following Shared Care Protocols are organised by generic drug name.
|Protocol Number ||Drug ||Indication |
|CV44||Amiodarone (SCP and Agreement form) ||Severe cardiac rhythm disorders |
|CV02||Apomorphine ||Disabling Motor Fluctuations in Parkinson's Disease |
|CV51||Azathioprine ||Auto-immune conditions, usually when corticosteroid therapy alone provides inadequate control |
|CV04||Azathioprine ||Liver Transplantation in Adults |
|CV 29||Ciclosporin ||Rheumatoid Arthritis |
|CV20||Disulfiram ||Maintenance of abstinence in alcohol dependence |
|CV38||Dornase alfa ||Cystic fibrosis |
|CV40||Lanreotide (Somatuline Autogel) ||Acromegaly, Carcinoid Syndrome and other Peptide Hormone Secreting Tumours |
|CV11||Leflunomide ||Rheumatoid Arthritis and Psoriatic Arthritis |
|CV 22||Leuprorelin ||Precocious Puberty in Children |
|CV12||Lithium ||Prophylaxis of Mania, Bipolar Disorder, Recurrent Depression |
|CV25||6MP ( 6-Mercaptopurine) ||Inflammatory Bowel Disease |
|CV54||Melatonin ||For children and adolescents (up to and including 18 years) with significant sleep onset difficulties |
|CV55||Methotrexate ||Rheumatoid Arthritis and various auto-immune conditions, usually when corticosteroid therapy alone provides inadequate control |
|CV01||Methylphenidate, lisdexamfetamine and atomoxetine ||Attention deficit hyperactivity disorder (ADHD) as part of a comprehensive treatment programme in children aged 6 years of age and over, young people and adults. |
|CV53||Mycophenolate mofetil ||Various conditions, which characteristically respond to immunosuppressive therapy |
|CV33||Octreotide LAR (Sandostatin LAR) ||Acromegaly, Carcinoid Syndrome and other Peptide Hormone Secreting Tumours |
|CV17||Penicillamine ||Rheumatoid Arthritis |
|CV39||Riluzole ||Amyotrophic Lateral Sclerosis (ALS) |
|CV19||Sodium aurothiomalate (Myocrisin) ||Rheumatoid Arthritis |
|CV34||Somatropin ||Adult Growth Disorders |
|CV 27||Somatropin ||Growth Hormone in Children |
|CV41||Sulfasalazine ||Inflammatory Bowel Disease (Crohn's and ulcerative colitis) |
|CV21||Sulfasalazine ||Rheumatoid Arthritis |
|CV43||Tacrolimus ||Liver Transplantation in Adults |
|CV 48||Tobramycin ||Chronic colonisation with pseudomonas aeruginosa in cystic fibrosis |
|CV 23||Triptorelin ||Precocious Puberty in Children |
Upload of updated protocols CV no. 11, 17, 19, 21, 25, 29, 41, 51, 55
Shared Care Incident Report Form updated.
Letter to GP added. Shared care list for GPs updated.
Shared care list for GPs updated.
Guidance documents updated.